Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland

被引：45

作者：

Laiho, K ^{[1
]}

Tiitinen, S ^{[1
]}

Kaarela, K ^{[1
]}

Helin, H ^{[1
]}

Isomäki, H ^{[1
]}

机构：

[1] Rheumatism Fdn Hosp, FIN-18120 Heinola, Finland

来源：

CLINICAL RHEUMATOLOGY | 1999年 / 18卷 / 02期

关键词：

amyloidosis ankylosing spondylitis; juvenile chronic arthritis; psoriatic arthritis; rheumatoid arthritis;

D O I：

10.1007/s100670050068

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

We studied whether the high incidence of secondary amyloidosis (SA) is a consistent finding in patients with inflammatory joint disease. A total of 4508 biopsies of patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis were studied at the Rheumatism Foundation Hospital during 1987-1997. The results show that the annual number of findings of SA was reduced from 68 to less than 10. We suggest that a change in medication towards more frequent use of cytostatic, agents is the reason for the reduction in incidence of SA.

引用

页码：122 / 123

页数：2

共 14 条

[1]

METHOTREXATE IN REFRACTORY RHEUMATOID-ARTHRITIS [J].